38 , 39 , 40 It is important to highlight that other research on remyelination in patients with MS 41 , 42 indicated significant effects on paraclinical measures after a 90-day follow-up; therefore, because of the shorter duration of this trial, electrodiagnostic improvement is less likely to be significant.
← all excerpts
Evaluation of Clemastine's Effects on Clinical and Electrodiagnostic Parameters in Individuals With CTS: A Preliminary Placebo-Controlled Double-Blind RCT.
1
—
—